You are here

  • Home
  • Archive
  • Volume 18, Issue 4
  • Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study

Article metrics

Article menu
Download PDFPDF
Original Articles
Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2024

AbstractFullPdf
Jan 2019200
Feb 2019600
Mar 20191202
Apr 2019600
May 20192402
Jun 2019601
Jul 20191001
Aug 2019600
Sep 20191201
Oct 2019200
Nov 2019403
Dec 2019800
Jan 20201000
Feb 2020800
Mar 2020600
Apr 2020200
May 20201000
Jun 2020700
Jul 2020800
Aug 2020400
Sep 20201402
Oct 2020400
Nov 2020200
Dec 2020400
Jan 2021400
Apr 2021500
May 2021100
Jul 2021101
Oct 20212000
Dec 20211000
Jan 20221500
Feb 20221900
Mar 20222202
Apr 2022800
May 20223500
Jun 20223200
Jul 20221500
Aug 20223400
Sep 20224000
Oct 20223400
Nov 20221400
Dec 20221201
Jan 2023200
Feb 20233800
Mar 2023600
Apr 2023400
May 2023300
Jun 2023400
Jul 2023200
Aug 20231202
Sep 2023200
Oct 2023400
Nov 20231200
Dec 20231400
Jan 20241400
Feb 2024400
Mar 2024200
Apr 2024600
Total627018